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doi:10.1016/j.jtcvs.2006.02.036bjective: We determined the possible effects of age, antimineralization treatments,
irculatory implant conditions, prosthesis design, and valve-related structural as-
ects on valve calcification in adolescent sheep.
ethods: Calcium content was measured by means of atomic absorption spectrom-
try in bioprostheses implanted in 120 sheep (age 1 year) for a period of 3 or 6
onths.
esults: Bioprostheses calcified significantly in adolescent sheep, but the extent of
alcification was multifactorial. Multivariate analysis of the calcium content reveals
hat age, mitral or pulmonary implant position, prosthesis design (stented or stent-
ess), structure (porcine or pericardial, wall portion or cusp), and antimineralization
reatment are independent factors influencing calcification; implant duration beyond
months was not. In juvenile sheep (age 5 months) the wall portion, as well as the
usps of the prosthesis, calcified significantly more than in adolescent sheep (age 11
onths). Irrespective of age, the cusps of valves implanted in the mitral position
alcified more than those in the pulmonary position. The wall portion of stentless
alves calcified more than that of stented valves, and pericardial valves calcified less
han porcine valves. The surfactant (Tween 80, No-React, and -amino-oleic acid)
nd alcohol (ethanol and octanediol) treatment significantly reduced cusp calcifi-
ation; sodium dodecylsulfate did not. None of the anticalcification treatments
ble to prevent wall calcification in stentless porcine valves.
onclusion: These findings suggest that tissue valve calcification is determine
any independent factors, which can be identified by using adolescent shee
rec linical in vivo model.
fter implanting more than 1500 heart valves in sheep over the years,
Michael Jones at the National Heart, Lung, and Blood Institute developed
the juvenile sheep model for testing biologic heart valves.1 Calcium content
f the valves was detelrmined by means of atomic spectrometry after impla
or 20 weeks in the mitral or tricuspid position. The objective was to study various
ntimineralization treatments, and he found that there was a very wide distribution
ange of calcium content for each valve treatment as a function of individual
nimals. Therefore a large number of complete experiments are needed to determine
he efficacy of a given treatment. In spite of the variability of the calcifications
etween animals and the inhomogeneity of the calcium deposits within the same
alve, calcium content measurement with atomic absorption spectroscopy is still
ccepted as the gold standard. Alternative techniques are soft radiographic assessment
f valve calcifications or histologic determination of calcium deposits in the valve tissue.
ow much the results of these techniques correlate with each other is unclear.
A problem with the use of juvenile animals is their growth potential: they stillrow considerably, and a severe patient-prosthesis mismatch can occur. This could
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CSPe avoided by using adolescent or adult animals for valve
esting. Unfortunately, little is known about accelerated
alcification in these grown-up animals.
The aim of the present study was to evaluate accelerated
alcification of bioprosthetic heart valves in adolescent
heep and to study the potential to differentiate between
ntimineralization treatments in this animal model. There-
ore we studied the effect of age (juvenile vs adolescent),
mplant position (left or right side), implant duration (3 vs 6
onths), valve tissue material (porcine aortic valve or bo-
ine pericardium, aortic wall portion or cusps), valve design
stented or stentless), and antimineralization treatment on
alve calcification.
aterials and Methods
ll animals were cared for by a veterinarian in accordance with the
Guide for the care and use of laboratory animals” published by
he National Institutes of Health (National Institutes of Health
Abbreviations and Acronyms
AOA -amino-oleic acid
KUL  Katholieke Universiteit Leuven
SDS  sodium dodecylsulfate
ABLE 1. Chronically implanted bioprostheses: Valve and
Design Name
orcine Stented Mosaic (305)
Hancock MO
Hancock II
Epic (ELS)
Epic (ELS)
Labcor Duranol (TLPB-A)
Labcor Duranol (TLPB-A)
Labcor (4891-A/TLPB-A)
Labcor (4891-A)
Biocor genetic (H3636)
Aspire AorTech (A-44)
Hancock I pulmonary valved conduit
Stentless Freestyle aortic root
Prima Plus (2500 P)
Toronto SPV (SPA-101)
Photofix
Labcor pulmonary conduit (TO 7EAIS)
Biocor No-React I
ericardial Stented Perimount (2900)
Perimount (2900)
Pericarbon
Stentless Pericarbon
otal no. of animals
orcine, Porcine aortic tissue; Pericardium, bovine pericardial tissue; A, ad
DS, sodium dodecylsulfate; Linx (manufactured by St Jude Medical, Inc, St Pa
0 The Journal of Thoracic and Cardiovascular Surgery ● July 2ublication no. 85-23, revised 1985). The study was approved by
he Ethics Committee of the Katholieke Universiteit Leuven
KUL). One hundred twenty-six female Lovenaar sheep, younger
han 12 months of age and weighing between 29 and 63 kg, were
btained from the Zoötechnical Center from the KUL and were
uarantined at the animalium facility of the KUL before undergo-
ng cardiac surgery.
alves Studied
ifteen different types of tissue valves were used in this study. The
ypes and their major characteristics are presented in Table 1
alves are aortic prostheses and are made by the following man-
facturers: Medtronic, Inc, Minneapolis, Minn (Mosaic, Hancock
O, Hancock II, Hancock I pulmonary valved conduit, Freestyle
ortic root); St Jude Medical, Inc, St Paul, Minn (Epic, Toronto
PV; Sulzer Carbomedics—Photofix); Labcor Laboratorios, Bela
orizonte, Brazil (Labcor, Labcor Duranol, Labcor pulmonary
onduit); BioVascular, Inc, St Paul, Minn (Biocor genetic); Sorin
iomedica, Saluggia, Italy (Pericarbon stented, Pericarbon stent-
ess); Edwards Lifesciences, Irvine, Calif (Prima plus, Perimount);
iocor Industria e Pesquisas Ltda, Belo Horizonte, Brazil (Biocor
o-react I); AorTech Europe Ltd, Strathclyde, Scotland (Aspire
orTech).
urgical Intervention
Mitral valve replacement. Operations occurred after achieve-
ent of general anesthesia. After a left thoracotomy was carried
ant characteristics
Implant
position
Valve size
(range)
Implant duration
Treatment Fixation3 mo 5-6 mo
P 21 n  3 n  3 AOA GA
P 19-25 n  3 n  3 None GA
M 23 n  5 SDS GA
P 21-23 n  3 n  3 Linx GA
M 23 n  3 Linx GA
P 21 n  6 Octanediol GA
M 23 n  3 n  2 Octanediol GA
P 21-23 n  3 n  5 None GA
M 23-25 n  2 None GA
P 21-23 n  1 n  3 None GA
M 23 n  1 n  5 None GA
P 20 n  3 None GA
P 21-23 n  3 n  3 AOA GA
P 21-23 n  3 n  3 Tween 80 GA
P 19-22 n  9 n  3 None GA
P 21-23 n  3 n  2 None DMPO
P 15-17 n  3 None GA
P 21-23 n  3 n  3 No react None
P 21-23 n  3 n  3 Tween 80 GA
M 23 n  2 n  3 Tween 80 GA
P 21-25 n  3 n  3 None GA
P 19-23 n  3 n  2 None GA
120
ent; P, pulmonary; AOA, -amino-oleic acid; GA, glutaraldehyde; M, mitral;impl
Age
A
A
A
A
A
A
A
A
A
A
A
J
A
A
A
A
J
A
A
A
A
A
olesc
ul, Minn); J, juvenile; DMPO, dye-mediated photo-oxidation.
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Put, the animals were started on cardiopulmonary bypass, and
itral valve replacement was performed.2
Pulmonary valve replacement. After achievement of general
nesthesia and artificial ventilation, a left thoracotomy was carried
ut. After administration of heparin (3 mg/kg), a pneumatic right
entricular assist device (Medos HIA-VAD; Medos-Helmholtz
nstitute, Aachen, Germany) was installed, with the inflow cannula
n the right atrium and the outflow cannula 1 cm proximal from the
ulmonary bifurcation. The prosthetic valve was implanted as an
nterposition in the pulmonary artery. In this way stentless valves
ere placed into position as a whole root. The native pulmonary
alve was destroyed by tearing 2 cusps, and then the right ven-
ricular assist device was stopped and removed.3
After mitral or pulmonary valve replacement, removal of the
annulas, and careful hemostasis, the chest was closed in layers,
ith a chest drain in the left pleural space.
No inotropic drugs are used during the procedure. The animal
as ventilated at all times. After extubation, the animals returned
o the controlled animal facility, where the general health of the
heep was checked daily.
xperimental Models
he combination of animal age, implant position, type of valve
esign, and type of tissue resulted in the following experimental
odels: (1) adolescent, mitral, stented, porcine or pericardial; (2)
dolescent, pulmonary, stented or stentless, porcine or pericardial;
nd (3) juvenile, pulmonary, stented or stentless, porcine.
chocardiography
ransthoracic echocardiography was performed by an experienced
chocardiographer. This included a description of heart valve mo-
ion from the prosthetic implant in the pulmonic or mitral position.
nimal Death
he animal was prepared and anesthetized as described above,
dministered heparin (3 mg/kg) intravenously, and killed with an
verdose of a KCl solution administered intravenously, and the
eart was removed. The implanted bioprosthesis was excised, and
acroscopic and soft radiographic images were taken (Figure
he valves were analyzed as described below.
issection of the Explanted Valve
hree sections of the valve were obtained by severing the com-
issures, each containing a complete cusp and a wall portion.
etal parts of the stents were removed in case of stented valves.
hen every section was divided into 2 equal parts (Figure A).
ne part was used for histology (hematoxylin and eosin and Von
ossa staining, Figure 2), and the other part was used for ca
ontent determination after further sampling. The cusp portion was
ivided into 3 parts: the commissural area, basal part, and free
dge (Figure 1, A, parts 1, 2, and 3). The wall portion was
ivided into 2 parts: the inflow part and the outflow part (Fig
, parts 4 and 5). This resulted in 9 cusp samples and 6 wall
amples in every valve.
uantitative Calcium Determination
fter lyophilization, the tissue was pulverized and desiccated toonstant weight in an oven. Pulverized tissue was diluted in 20%
The Journal of Thorac1,
igure 1. Illustration of macroscopic findings. A, Diagram demon-
trating the dissection of the explanted valve for atomic absorption
pectrometry measurements. By severing the commissures, the
alve was divided into 3 parts, each containing a complete cusp and
wall portion. Half of each of the 3 segments (gray area) of the valve
s used for quantitative calcium determination. The leaflet is divided
nto the commissural region (1), the basal portion (2), and the free
dge (3). The wall is divided into the outflow (4) and inflow (5)
ortions. This results in 9 leaflet parts and 6 wall parts per valve.
, Gross pathology of an explanted Perimount valve. C, Radio-
raph of the same Perimount valve. Calcium is present at the
ommissures.ic and Cardiovascular Surgery ● Volume 132, Number 1 91
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CSPydrochloric acid at a ratio of 10 mg of dried tissue to 1 mL of
Cl. Calcium content was measured by means of flame atomic
bsorption spectrometry and expressed in micrograms per milli-
ram of dry weight.
Quantitative calcium content analysis was performed on about
0% of the valve tissue material, as described above.
Nonimplanted control valves. In 23 valves that were never
mplanted, calcium content was determined, as described above.
his series included 345 samples originating from 2 Toronto, 1
abcor Duranol, 2 Freestyle, 3 Epic, 2 Labcor, 2 Mosaic, 5
ericarbon stented, 4 Perimount, and 2 Aspire Aortech valves.
Short-term implants. Six valves were recovered from animals
hat died early (1-5 days) after the operation: 1 Hancock II, 1
spire Aortech, 1 Toronto, and 3 Pericarbon stented valves. Cal-
ium content was determined in a total of 90 samples.
Chronically implanted valves. A total of 120 chronically im-
lanted valves (Table 1) were used in this study. Fifteen sa
er valve were analyzed on calcium content, which resulted in
721 values.
ata Management and Statistical Analysis
ormal probability plots (with the Shapiro-Wilks test for normal-
ty) were constructed to judge data distribution. Given the impor-
ant skewed, nonnormal distribution of the calcium content data,
ogistic transformation was performed (Figure 3). Further stat
al analysis consisted of multiple linear regression modeling with
backward stepwise selection technique after insertion of all
ariables with a univariate P value of less than .1 (univariate
nalysis by t tests).
Groupwise comparison of anticalcification treatments was per-
ormed on the original calcium content data by using nonparamet-
ic techniques (Kolmogorov-Smirnov testing, completed with sep-
rate Mann-Whitney U tests). Consequently, when dealing with
he original data, medians and interquartile ranges are used in the
lots.
esults
ortality and Morbidity
n total, 126 sheep underwent operations. Six animals died
s a result of the surgical intervention (bleeding and low
ardiac output) within 5 days postoperatively. The remain-
ng 120 sheep having no clinical symptoms were neverthe-
ess tested on silent endocarditis: sections of the explanted
alves were stained (Gram-Pas-Grocott) for histologic di-
gnosis of tissue infection.
chocardiography
ll prosthetic valves functioned well at 1 week. There were
o signs of valve thrombosis recorded. Also, at autopsy,
here was no additional thrombus found in and around the
ative pulmonary valve, which was destroyed during the
peration.
pacial Distribution of Valve Calcification
hen all the data obtained from explanted bioprosthesesigure 2. Representative illustration of histologic findings. A,
iagram of longitudinal section through an explanted stented
alve. a, Wall portion; b, leaflet; c, pannus overgrowth; d, Dacron
loth. B, Photomicrograph of hematoxylin and eosin–stained sec-
ion of an explanted Aspire Aortech valve 6 months after implan-
ation. C, Photomicrograph of Von Kossa–stained section. Cal-
ium is visible at the top of the aortic wall portion and, to a lesser
xtent, around the suture near the annulus.fter chronic implantation are considered, calcification in
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Phe cusps is significantly lower than in the aortic wall
ortions of the valve (P  .001). Within the cusps, the
ighest calcium levels are found in the commissures, and
he lowest calcium levels are found in the edges of the cusp.
here is no prevalence for calcification between cusps (
re 4, A). In the wall portion of the valve, the highest v
re found in the outflow part of the valve (Figure 4, B). The
ature of the calcification was studied in the histologic
n the outflow portion of the wall. *P < .002. Rc, Right coronary c
usp base; Lc, left coronary cusp commissure; Le, left coronary
ommissure; Ne, noncoronary cusp free edge; Nb, noncoronary cu
all right coronary cusp; Lwi, inflow part wall left coronary cu
oncoronary cusp; Now, outflow part noncoronary cusp.ections. Extrinsic calcification was found in 9 of 120 valves T
The Journal of Thoracs
nd was located in the pannus formation at the base of the
eaflets. This was found in 4 stentless valves (Biocor I,
rima plus, Toronto, and Pericarbon) and 5 stented valves
Labcor, Labcor Duranol, Mosaic, and 2 Pericarbon valves).
ll theses valves were implanted in the pulmonary position.
ll other calcifications were intrinsic calcifications. The
ifferences in calcification between the porcine valve types
re analyzed by using multiple comparisons, as presented in
Figure 3. Distribution of calcium
content data and concomitant
normal probability plots. The up-
per panels show the extreme
skew distribution of the calcium
content data, with a strong de-
viation from a straight line in the
normal probability plot. Logistic
transformation of the original
data results in a normal distri-
bution (lower panels).
Figure 4. Spatial distribution of
valve calcification. The graphs
shows median values, with the
interquartile range (rectangular
box) and nonoutlier range (non-
outlier range  all values of the
1.5  interquartile range inter-
val). A, Calcium content in dif-
ferent cusp parts, separated for
right, left, and noncoronary
cusps. B, Calcium content in in-
flow and outflow parts of the
wall portion of the prosthesis.
Consistently higher values are
seen in commissural parts and
ommissure; Re, right coronary cusp free edge; Rb, right coronary
free edge; Lb, left coronary cusp base; Nc, noncoronary cusp
ase; Rwi, inflow part wall right coronary cusp; Rwo, outflow part
wo, outflow part wall left coronary cusp; Nwi, inflow part wallusp c
cusp
sp b
sp; Lable 2. It is shown that many valve types differ in their
ic and Cardiovascular Surgery ● Volume 132, Number 1 93
ca
e
r
u
v
t
p
c
F
U
i
w
(
m
o
s
m
f
p ysis
o
p
j
o
n
T
S
S
S
S
A
.
T
I
A
P
D
O
A
T
m
s
w
t
p
Cardiopulmonary Support and Physiology Flameng et al
9
CSP
alcium content, which might be related, in addition to the
ge of the sheep, to factors like fixation process, antimin-
ralization treatment, and design. Indeed, these valves rep-
esent multiple generations of valves and valve design. To
nravel the significance of the different factors influencing
alve calcification, multiple types of valves were grouped
ogether, and a univariate and multivariate analysis was
erformed by using the logistically transformed calcium
ontent data.
actors Influencing Valve Calcification
nivariate analysis revealed that calcium content is signif-
cantly (P  .05) related to valve part or fraction (cusp or
ABLE 2. Nonparametric comparison (Kruskal-Wallis) of a
Hancock
NT
Biocor
gen Aspire Labcor
tented;
No Am
Hancock NT
Biocor genetic —
Aspire AorTech *** —
Labcor ** *** ***
tentless;
No Am
Labcor p conduit *** — — ***
Toronto SPV — * *** —
tented;
Am
Hancock II — — — ***
Mosaic *** *** *** —
Labcor Duranol — ** *** —
Epic — ** *** —
tentless;
Am
Prima Plus *** *** *** —
Photofix *** *** *** —
Freestyle *** *** *** —
Biocor No-React I — ** *** —
m, Antimineralization treatment; NT, nontreated; Hancock NT, includes H
05, **P  .01, ***P  .001.
ABLE 3. Univariate and multivariate analysis of calcium
Cusp
Univariate
analysis Multivariate
P value  P value
mplant duration (3 mo/6 mo) .00001 0.0328 NS
ge (juvenile/ adolescent) .00001 0.3135 .0001
osition (pulmonary/mitral) .00001 0.2591 .0001
esign (stented/stentless) .0018 0.0502 NS
rigin (porcine/bovine
pericardial)
.00001 0.2309 .0001
nticalcification treatment
(treated/nontreated)
.0011 0.1479 .0001
ests used are t tests and multiple linear regression with the logistical
ultivariate model because all univariate P values were smaller than .1.
ignificance at the univariate level. The multivariate analysis for the cusp
all, implant position is the only nonsignificant variable. All other variables
he magnitude of the effect. NS, not significant; A, adolescent; J, juvenile;
ericardium; T, treated; NT, nontreated.all portion), age (juvenile or adolescent), tissue origin l
4 The Journal of Thoracic and Cardiovascular Surgery ● July 2porcine or pericardial), treatment (antimineralization treat-
ent or not), implant position (mitral or pulmonary), tissue
rigin (porcine or pericardial), and valve design (stented or
tentless). Extending the implantation duration from 3 to 6
onths did not increase calcification further (P  .05). For
urther univariate and multivariate analysis, cusp and wall
ortion data were separated (Table 3). Multivariate anal
f the cusp data reveals the following factors as independent
redictors of calcification: age of the animal (adolescent 
uvenile), implant position (pulmonary  mitral), tissue
rigin (pericardial  porcine), and valve treatment (treated
ontreated). Valve design (stented or stentless) and, again,
rcine valve types in the study (cusp values)
Toronto
Hancock
II Mosaic
Lab
Dur Epic
Prima
Plus Photofix Freestyle
***
— ***
— *** —
— *** — —
— *** — — —
* *** — — — —
— *** — — — — —
— *** — — — — — —
ck I valved conduit and Hancock MO; —, no significant difference. *P 
ent data
Wall
sis
Univariate
analysis Multivariate analysis
Level P value  P value Level
o  6 mo NS 3M mo  6 mo
J .00001 0.2084 .0001 A  J
M .035 0.0632 NS P  M
 Sl .00004 0.1890 .0001 St  Sl
 BP .00001 0.3757 .0001 PA  BP
NT .0052 0.1363 .0005 T  NT
nsformed calcium content data. For the cusp, all variables entered the
he wall, the factor implant duration was excluded because of a lack of
ls the implant duration and the design as nonsignificant variables. For the
ithheld as significant predictors for calcium content. The  value indicates
monary; M, mitral; St, stented; Sl, stentless; PA, porcine aorta; BP, bovinell po
Lab
con
***
—
***
***
***
***
***
***
***
ancocont
analy
3 m
A 
P 
St
PA
T 
ly tra
For t
revea
are w
P, pulong-term duration of implantation (3 or 6 months) is not a
006
sd
c
(
v
l
.
w
o
o
i
i
v
c
o
i
1
i
p
t
m
t
c
p ation
c
n
s
c
s all
p
c
p
a
s
p con-
s
i
t
t
t
(
s
t
d  is
o
f
b
s
v
t
p
a
p
v
l
t
t
v
.
i 3).
1
Flameng et al Cardiopulmonary Support and Physiology
CS
Pignificant predictor. For the wall portion, age, tissue origin,
esign, and treatment are independent predictors of calcifi-
ation (P  .05), but position and implant duration are not
P  .05).
Effect of implantation duration. In the not-implanted
alves calcium content was 0.38  0.31 g/mg for the
eaflets, 0.38  0.30 g/mg for the aortic wall portion (P 
05), and 0.38  0.30 g/mg for the entire valve. There
ere no differences found in calcium content between types
f valves (P  .05). This resulted in an upper calcium limit
f 1 g/mg (mean value  2 standard deviations), indicat-
ng normal baseline calcium content of the valves before
mplantation.
These results were compared with those originating from
alves that were implanted for only 1 to 5 days. Calcium
ontent was significantly higher than in corresponding areas
f similar types of nonimplanted valves: 1.47 0.85 g/mg
n the leaflets, 1.59  0.96 g/mg in the wall portion, and
.52  0.89 g/mg in the entire valve (P  .05).
In adolescent sheep the overall calcium content of valves
ncreased about 10 times during the first 3 months of im-
lantation (to 14.3 g/mg) but remained at this level during
he next 3 months.
Juvenile versus adolescent sheep. As described above,
ultivariate analysis of the calcium content data revealed
hat age was a significant and independent factor of in-
reased calcification for the cusp as for the aortic wall
ortion (Table 3). In an effort to quantify these calcific
haracteristics, calcium content was determined in all juve-
ile (5 months of age) and adolescent (11 months of age)
heep. The results are as follows: in juvenile sheep overall
alcium content was several times higher than in adolescent
heep, in the leaflets (Figure 5, A) as in the aortic w
ortion (Figure 6, A).
Implant position. Multivariate analysis of the data indi-
ated that the position of valve implantation (mitral or
ulmonary) is an independent factor of valve calcification,
Figure 5. Calcium content values in the cusp. The g
(rectangular box) and nonoutlier range. A, Calcium co
calcium content in pulmonary (P) and mitral (M) impla
bovine pericardial (BP) cusps. *P < .00001.
The Journal of Thoraclthough only for the cusps. Calcification of the leaflets is
ignificantly higher after mitral than after pulmonary im-
lantation (Table 3). When the aortic wall portion is 
idered, no significant effect of implant position is found.
When the calcium contents at 3 to 6 months of all valves
mplanted in the pulmonary position are compared with
hose of all valves at the same time interval but implanted in
he mitral position, calcium content of the leaflets was about
wice as high in the mitral than in the pulmonary implants
Figure 5, B).
Valve design and tissue material. The multivariate analy-
is indicated that valve design (stented or stentless) and
issue material (pericardium or porcine aorta) are indepen-
ent factors influencing calcification (Table 3). Stenting
nly an independent predictor of wall calcification and not
or cusp calcification, but tissue material is important for
oth wall and cusp calcification. When the results of all
tented valves are compared with those of all stentless
alves, stentless valves calcify more than stented valves in
he wall portion (Figure 6, B). Valves constructed from
ericardial tissue calcify less than valves made of porcine
ortic roots. When all porcine valves are compared with all
ericardial valves, calcium content is higher in the porcine
alves compared with that in the pericardial valves, in the
eaflets (Figure 5, C) as in the wall portion (Figure 6, C).
Antimineralization treatment. When the calcium con-
ent data of valves that received any kind of antimineraliza-
ion treatment were compared with those of nontreated
alves, a significantly lower calcification was found (P 
001). Multivariate analysis indicated that treatment was an
ndependent factor influencing valve calcification (Table 
The following antimineralization treatments were included:
. surfactants: sodium dodecylsulfate (SDS; Hancock II
valve), polysorbate 80 (Tween 80: Perimount, Prima
Plus valves), No-React (No-React: Biocor No-React I
shows median values, with the interquartile range
in cusps of adolescent (A) and juvenile (J) sheep. B,
cusps. C, Calcium content in porcine aortic (PA) andraph
ntent
ntedic and Cardiovascular Surgery ● Volume 132, Number 1 95
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CSPvalves), and -amino-oleic acid (AOA; Mosaic, Free-
style valves) and
. alcohols: octanediol (Duranol: Labcor Duranol valve)
and ethanol (Linx: Epic valve).
For the leaflets, any form of antimineralization treatment
ested resulted in less calcification than the nonuse of treat-
ent, except for SDS (Figure 7, A). Concerning the wa
ortion in stentless valves, no treatment had a significant
ffect in reducing calcification (Figure 7, C). In stented valve
he limited wall portion that is present calcifies less when an
ntimineralization treatment is applied (Figure 7, B).
iscussion
his study shows that the calcification potential of adoles-
ent sheep is considerable and not exclusive for juvenile
nimals. This can be related to the still-enhanced calcium
etabolism in these young animals.4 Although the calcifi-
Figure 6. Calcium content values in the wall. The g
(rectangular box) and nonoutlier range. A, Calcium co
B, Calcium content in the wall of stented (Std) and ste
(PA) and bovine pericardial (BP) wall. *P < .0003.
Figure 7. Calcium content values in valves treated with
values, with the interquartile range (rectangular box)
valves). Nontreated (No) and sodium dodecylsulfate
content. B, Calcium content in the wall of stented valv
content compared with valves treated with anticalcifi
valves. Significant differences between treatments are
Medical, Inc, St Paul, Minn).ation potential in adolescent sheep is less than that in i
6 The Journal of Thoracic and Cardiovascular Surgery ● July 2uvenile sheep, it is powerful enough to reveal the factors
nfluencing calcification processes and to distinguish be-
ween the effects of different antimineralization treatments.
The finding that young age is an important determinant
f tissue prosthesis calcification is not surprising. It has been
ong known from clinical implants that prosthetic valve
alcification and its consequences are strongly related to
atient age at implantation.5
It was, and perhaps still is, believed that pericardial and
orcine tissue equally calcifies with time when used as a
rosthetic construct. This originates from the finding that
oth tissues have the same potential for calcification when
mplanted subcutaneously in rats. This, however, does not
mply that they, as valve constructs, will calcify to the same
xtent. Indeed, results from rats cannot be freely extrapo-
ated to other species1 and certainly not when blood cont
onditions are involved.6 Nevertheless, the extensive wor
shows median values, with the interquartile range
in the wall of adolescent (A) and juvenile (J) sheep.
s (Sless) valves. C, Calcium content in porcine aortic
rent anticalcification agents. The graph shows median
onoutlier range. A, Calcium content in the cusps (all
)–treated valves have a significantly higher calcium
ontreated valves have a significantly higher calcium
n agents. C, Calcium content in the wall of stentless
und. *P < .05. AOA, -Amino-oleic acid Linx (St Juderaph
ntent
ntlesdiffe
and n
(SDS
es. N
catio
not fon sheep from Jones and colleagues1 and Gallo and associ-
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Ptes7 could not differentiate between the calcification ra
f porcine or pericardial valves. The problem is that a
ixture of different porcine valves was compared with a
ixture of different pericardial valves from different man-
facturers. Recently, a sophisticated in vitro technique using
olographic interferometry was developed to test tissue
alcification.8 When comparing pericardial valves from o
anufacturer with porcine bioprostheses from different
anufacturers, no differences in calcification rates can be
ound.8 It was concluded that the biologic material of
rosthesis (pericardial or porcine) is not the crucial factor
ut that mechanical stresses have a much more pronounced
ffect on calcification. Nevertheless, using the same tech-
ology, Glasmacher and coworkers9 demonstrated that peri-
ardial valves are less prone to calcification than porcine
alves when valves from the same manufacturer are com-
ared. Our findings in the present study suggest also that
issue source is an independent predictor of valve calcifica-
ion in the sense that pericardial valves calcify less than
orcine valves. This was confirmed by clinical data when
he long-term performance of Carpentier-Edwards porcine
ioprostheses and Carpentier-Edwards pericardial biopros-
heses were compared.10 It was found that 10-year freedo
rom explantation was lower for the porcine (90%  2%)
han for the pericardial (97%  2%, P  .04) valves. The
ncidence of structural valve degeneration was much higher
n porcine than in pericardial valves.
This, however, does not mean that pericardial biopros-
heses do not calcify: it was extensively shown in she1,7
nd in human subjects11-13 that pericardial prostheses o
ifferent designs and from different manufacturers calcify at
ifferent rates. It has long been known that mechanical
tress stimulates calcification,14 and it was clearly shown 
eiwick and colleagues8 that valve calcification strongl
orrelates with stress distribution within the valve. This
xplains the significant influence of valve design on valve
alcification.
In the present study several aspects of this interrelation-
hip among valve design, valve structure, and calcification
haracteristics come about in the adolescent sheep model.
irst, there is the distribution of valve calcification. We
ould clearly show that at sites of increased mechanical
tress and strain, calcification was pronounced: predomi-
antly at the cuspal commissures, to a lesser extent at the
ase of the leaflet, and in the least at the free edge. This is
n agreement with the findings of Schoen and associa15
nd demonstrates again the sensitivity of the adolescent
heep model.
Remarkable in our studies comparing stented with stent-
ess valves16 was that the wall calcification occurs m
rogressively and more rapidly in stentless valves than in
heir stented counterparts. In previous studies we already
ocused attention on porcine wall mineralization of tissue p
The Journal of Thoracalves and revealed an important cell-mediated calcification
rocess.17 Besides the importance of dead cells and 
emnants as foci of early mineralization, the contribution of
lastin, elastolysis, and subsequent calcification of elastic
bers in the aortic wall portion was shown. Thus in general
he aortic wall calcifies more than the cusps, most probably
ecause of its typical highly cellularized structure, which
ontains more elastin. Obviously, stenting in itself reduces
ortic wall calcification, so that in stented valves the differ-
nce between cusp and wall calcification fades away or even
everses, especially after left-sided (mitral) valve implanta-
ion when increased stress accentuates cusp calcification.
his might explain why Biedrzycki and associates18 found
hat calcification in the aortic wall segments of failed
tented human porcine bioprostheses was approximately
alf that of cuspal calcification. All valves were failing in
he aortic or mitral position and were heavily calcified
66  6.3 g/mg). It was suggested by Trantina-Yates and
oworkers19 that the predominant calcification of the ao
all is species related and typical for sheep. They found a
istinctly higher value of aortic wall calcification in the
heep model compared with that seen in nonhuman pri-
ates. The problem with this study is that the difference in
ortic wall calcification can be age related rather than spe-
ies related because the sheep were juveniles and the age of
he baboons was unknown. Also, the finding that the aortic
all portion, mainly in stentless valves, calcifies more in the
ulmonary position is confirmed by human data: allograft
ortic valves or roots implanted in the right-sided circula-
ion frequently fail because of calcific stenosis, often pre-
ominantly in the aortic wall portion.20 Midterm echocar-
iographic follow-up studies after Ross operations also have
hown that homografts in the pulmonary position are prone
o a calcification and stenotic process. Independent predic-
ors of homograft failure in the pulmonary position were
oung age at the time of the operation and the use of aortic
nstead of pulmonary homografts.21
Schoen and colleagues22 suggested that the reduced ao-
ic wall calcification in stented valves might be related to the
act that the stent with cloth might block diffusion of
alcium-containing fluid from the adventitial side of the
ortic wall. Another possibility is that the valve stent re-
uces mechanical stress on the small aortic wall segment,
hich was trimmed contiguous with the cusps to a level
lightly distal to the commissures and incorporated into the
rosthesis. Until now, there have been no available system-
tic data on calcification of explanted stentless valves in
uman subjects, which makes further comparison with the
heep model impossible.
Another independent factor that influences cusp and wall
alcification is the implant position (left or right side).
rosthetic valve implantation in the left side of the heart (mitral
osition) accentuates calcification of the cusps, whereas right-
ic and Cardiovascular Surgery ● Volume 132, Number 1 97
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CSPided implantation accentuates calcification of the wall por-
ion. This was confirmed in human implants,18 with the
ighest calcium concentrations shown in the cusps in mitral
alve implants.
In general, biologic tissue used in the construction of
eart valve bioprostheses is glutaraldehyde treated to pre-
ent degeneration of the material after implantation. How-
ver, glutaraldehyde treatment is related to in vivo calcifi-
ation of the fixed tissue. Various preglutaraldehyde and
ostglutaraldehyde tissue treatments have been attempted to
vercome these detrimental effects. These include detergents
r surfactants, such as SDS and polysorbate 80 (Tween 80).
heir mode of action is mainly related to removal of cellular
emnants and phospholipids from the tissue, and their effect
as first described in juvenile sheep by Jones and col-
eagues.1 One has to distinguish between the anticalcifi-
ion effects of a given treatment on the leaflets or on the
alve wall portion. On the leaflets, both the detergents and
urfactants Tween 80, No-React, and AOA and the alcohols
thanol and octanediol have a similar effect as anticalcifi-
ation agents. S D S h a d n o effect on cusp protection (Fi
re 7, A ). AOA, Tween 80, and No-React had no e
gainst aortic wall calcification in porcine stentless
alves. In a previous study we could show that ethanol and
OA are superior to SDS as an antimineralization treat-
ent.23 Whether the No-React process reduces calcificati
o the level of the detergents or of the more effective
nticalcification treatments could not be determined from
ur adolescent sheep study. Because the mode of action of
his procedure was never clarified,24 it is difficult to explo
he real effects of these kinds of procedures.
In conclusion, we demonstrates that the adolescent sheep
odel is useful and sensitive in the study of bioprosthetic
eart valve prostheses, provided sufficient animals are used
o overcome variability in calcification data. Also, it became
lear that optimal valve testing should take into account the
ifferent independent factors influencing bioprosthesis cal-
ification. For example, valved conduits for right-sided im-
lantation in congenital heart disease should be tested in
uvenile sheep and in the pulmonary position, whereas
tented bioprostheses can be tested preferentially in adoles-
ent sheep in the mitral position.
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